← Open Payments lookup

JUSTIN RAY: Open Payments

NPI 1093013641 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$57,864 in 141 payments from 14 companies in 2025. Trend: 2023 $27,309 · 2024 $28,293 · 2025 $57,864

Speaker / faculty: $32,260Honoraria: $17,226Travel & lodging: $5,293Food & beverage: $3,078Education: $8
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc31$25,716
Axsome Therapeutics, Inc.48$22,518
ABBVIE INC.22$8,565
Alkermes, Inc.13$279
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$208
Vanda Pharmaceuticals Inc.5$169
Averitas Pharma Inc.1$150
Neurocrine BioSciences, Inc.3$72
Takeda Pharmaceuticals U.S.A., Inc.3$55
Lundbeck LLC3$54

Products named: SPRAVATO, Auvelity, VRAYLAR, ARISTADA, CAPLYTA, FANAPT, QUTENZA, INVEGA SUSTENNA.

Industry payments across VA — which companies pay providers there.